Loading...
Loading...
SEER| Name | Value |
|---|---|
| Revenues | 3.8M |
| Cost of Revenue | 2.0M |
| Gross Profit | 1.8M |
| Operating Expense | 27.7M |
| Operating I/L | -25.8M |
| Other Income/Expense | -0.0M |
| Interest Income | 4.8M |
| Pretax | -21.1M |
| Income Tax Expense | -4.8M |
| Net Income/Loss | -21.1M |
Seer, Inc. is a life sciences company specializing in developing and commercializing the Proteograph Product Suite, an integrated solution for proteomic studies in therapeutic and diagnostic research, and clinical trials. The suite includes consumables, automation instrumentation, and software, catering to academic institutions, life sciences and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes.
